The presence of homologues of rabbit cytochrome P-450 isozyme 5 in pulmonary and hepatic microsomal preparations from guinea pig, mouse, monkey, hamster, and rat was examined by immunoblotting and inhibition of metabolism of 2-aminofluorene with antibodies to isozyme 5. Homologues to isozyme 5 were detected in pulmonary preparations from all five species. However, only hepatic preparations from hamster, in addition to those from rabbit, contained detectable levels of this isozyme. With the exception of induction by phenobarbital in rabbit liver, treatment of animals with phenobarbital or tetrachlorodibenzo-p-dioxin did not increase hepatic or pulmonary content of isozyme 5 homologues or the amount of 2-aminofluorene metabolism inhibited by antibodies to isozyme 5. Metabolism of 2-aminofluorene was measured both colorimetrically (formation of a reduced iron chelate from the N-hydroxyfluorene metabolite) and radiochemically (separation of 3H-metabolites by high performance liquid chromatography and quantitation by scintillation counting). A turnover number of 48 nmol of product X min-1 X nmol of enzyme-1 for isozyme 5-catalyzed metabolism of 2-aminofluorene was determined with incubations containing isozyme 5 purified from rabbit lung. A similar turnover number was calculated from the rabbit hepatic microsomal activity inhibited by antibodies to isozyme 5 and the microsomal isozyme 5 content measured by immunoquantitation. In other species, amounts of metabolism inhibited by antibodies to isozyme 5 agreed qualitatively with relative staining intensities on immunoblots. In all species except the hamster, rates of total and isozyme 5-catalyzed metabolism of 2-aminofluorene were greater with pulmonary than with hepatic microsomal preparations from untreated animals.

Download full-text PDF

Source

Publication Analysis

Top Keywords

metabolism 2-aminofluorene
16
antibodies isozyme
16
isozyme
13
hepatic microsomal
12
inhibited antibodies
12
homologues rabbit
8
rabbit cytochrome
8
cytochrome p-450
8
p-450 isozyme
8
pulmonary hepatic
8

Similar Publications

Differences in metabolite genotoxicity test results of rat liver S9 microsomes treated with various microsomal enzyme inducers.

Toxicol Mech Methods

January 2025

Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.

The rat S9 microsome fraction is commonly used to assess compound metabolite formation during genotoxicity assessments. However, methods using S9 have not been standardized for genotoxicity studies, and different experimental methods are used at various facilities. Therefore, this study investigated whether the differences between the two experimental conditions (1) S9 inducers, phenobarbital + beta-naphthoflavones vs.

View Article and Find Full Text PDF
Article Synopsis
  • Existing Skin-on-a-Chip (SoC) technology faces limitations due to complex structures and the need for multiple devices, hindering the assessment of harmful chemicals that impact liver health after skin contact.
  • A new gravity-driven SoC was developed, featuring three layers of cell chambers (human skin, blood vessel cells, and liver cells) that allows for effective study of liver toxicity from exogenous chemicals, with validation through specific parameters.
  • This SoC accurately mimics the way chemicals are absorbed through the skin, processed in the bloodstream, and affect the liver, offering a potential substitute for animal testing in evaluating the safety of skin-penetrating chemicals.
View Article and Find Full Text PDF

Diesel exhaust has long been of health concern due to established toxicity including carcinogenicity in humans. However, the precise components of diesel engine emissions that drive carcinogenesis are still unclear. Limited work has suggested that nitrated polycyclic aromatic hydrocarbons (NPAHs) such as 1-nitropyrene and 2-nitrofluorene may be more abundant in diesel exhaust.

View Article and Find Full Text PDF

Molecular and Functional Characterization of -Acetyltransferases in Common Marmosets and Pigs.

Drug Metab Dispos

November 2022

Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan (Y.U., M.I., A.A., M.S.); Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan(S.U., K.B., N.M., H.Y.); and School of Veterinary Medicine, Kitasato University, Aomori, Japan (H.K.)

Arylamine -acetyltransferases (NATs) are drug-metabolizing enzymes that are essential for the metabolism of endogenous substrates and xenobiotics. The molecular characteristics of NATs have been extensively investigated in humans but remain to be investigated in common marmosets and pigs, animal species that are often used in drug metabolism studies. In this study, marmoset NAT1 and pig NAT1 cDNAs were isolated from liver samples and were characterized by molecular analyses and drug-metabolism assays.

View Article and Find Full Text PDF

Arylamine N-acetyltransferases catalyze the transfer of acetyl groups from the endogenous cofactor acetyl coenzyme A (AcCoA) to arylamine (-acetylation) and -hydroxy-arylamine (-acetylation) acceptors. Humans express two arylamine -acetyltransferase isozymes (NAT1 and NAT2) which catalyze both - and -acetylation but differ in genetic regulation, substrate selectivity, and expression in human tissues. We investigated recombinant human and expressed in an JM105 and expression systems as well as in Chinese hamster ovary (CHO) cells to assess the relative affinity of AcCoA for human NAT1 and NAT2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!